126 related articles for article (PubMed ID: 38215026)
1. Puerarin alleviates diabetic nephropathy by inhibiting Caspase-1-mediated pyroptosis.
Chen Q; Wang L; Wei X; Chen M; Zhang X; Mo R; Huang R; Liang T; Xu X
J Pharm Pharmacol; 2024 Mar; 76(3):213-223. PubMed ID: 38215026
[TBL] [Abstract][Full Text] [Related]
2. Carnosine alleviates podocyte injury in diabetic nephropathy by targeting caspase-1-mediated pyroptosis.
Zhu W; Li YY; Zeng HX; Liu XQ; Sun YT; Jiang L; Xia LL; Wu YG
Int Immunopharmacol; 2021 Dec; 101(Pt B):108236. PubMed ID: 34653727
[TBL] [Abstract][Full Text] [Related]
3. Caspase-11/4 and gasdermin D-mediated pyroptosis contributes to podocyte injury in mouse diabetic nephropathy.
Cheng Q; Pan J; Zhou ZL; Yin F; Xie HY; Chen PP; Li JY; Zheng PQ; Zhou L; Zhang W; Liu J; Lu LM
Acta Pharmacol Sin; 2021 Jun; 42(6):954-963. PubMed ID: 32968210
[TBL] [Abstract][Full Text] [Related]
4. Triptolide protects against podocyte injury in diabetic nephropathy by activating the Nrf2/HO-1 pathway and inhibiting the NLRP3 inflammasome pathway.
Lv C; Cheng T; Zhang B; Sun K; Lu K
Ren Fail; 2023 Dec; 45(1):2165103. PubMed ID: 36938748
[No Abstract] [Full Text] [Related]
5. ManNAc protects against podocyte pyroptosis via inhibiting mitochondrial damage and ROS/NLRP3 signaling pathway in diabetic kidney injury model.
Gao Y; Ma Y; Xie D; Jiang H
Int Immunopharmacol; 2022 Jun; 107():108711. PubMed ID: 35338958
[TBL] [Abstract][Full Text] [Related]
6. Alpha-kinase1 promotes tubular injury and interstitial inflammation in diabetic nephropathy by canonical pyroptosis pathway.
Cui X; Li Y; Yuan S; Huang Y; Chen X; Han Y; Liu Z; Li Z; Xiao Y; Wang Y; Sun L; Liu H; Zhu X
Biol Res; 2023 Feb; 56(1):5. PubMed ID: 36732854
[TBL] [Abstract][Full Text] [Related]
7. MiR-21-5p in macrophage-derived extracellular vesicles affects podocyte pyroptosis in diabetic nephropathy by regulating A20.
Ding X; Jing N; Shen A; Guo F; Song Y; Pan M; Ma X; Zhao L; Zhang H; Wu L; Qin G; Zhao Y
J Endocrinol Invest; 2021 Jun; 44(6):1175-1184. PubMed ID: 32930981
[TBL] [Abstract][Full Text] [Related]
8. Solasonine alleviates high glucose-induced podocyte injury through increasing Nrf2-medicated inhibition of NLRP3 activation.
Zhang Q; Hu Y; Hu JE; Zhang M
Drug Dev Res; 2022 Nov; 83(7):1697-1706. PubMed ID: 36048966
[TBL] [Abstract][Full Text] [Related]
9. Pyrroloquinoline quinone ameliorates renal fibrosis in diabetic nephropathy by inhibiting the pyroptosis pathway in C57BL/6 mice and human kidney 2 cells.
Qu X; Zhai B; Liu Y; Chen Y; Xie Z; Wang Q; Wu Y; Liu Z; Chen J; Mei S; Wu J; You Z; Yu Y; Wang Y
Biomed Pharmacother; 2022 Jun; 150():112998. PubMed ID: 35489281
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanism of GSDMD mediated glomerular endothelial cells pyroptosis: An implying in the progression of diabetic nephropathy.
Shao Y; Deng S; Tang W; Huang L; Xie Y; Yuan S; Tang L
Int Immunopharmacol; 2023 Sep; 122():110632. PubMed ID: 37451013
[TBL] [Abstract][Full Text] [Related]
11. LncRNA-antisense non-coding RNA in the INK4 locus promotes pyroptosis via miR-497/thioredoxin-interacting protein axis in diabetic nephropathy.
Wang J; Zhao SM
Life Sci; 2021 Jan; 264():118728. PubMed ID: 33160992
[TBL] [Abstract][Full Text] [Related]
12. Gasdermin D is involved in switching from apoptosis to pyroptosis in TLR4-mediated renal tubular epithelial cells injury in diabetic kidney disease.
Yuan S; Wang Y; Li Z; Chen X; Song P; Chen A; Qu Z; Wen S; Liu H; Zhu X
Arch Biochem Biophys; 2022 Sep; 727():109347. PubMed ID: 35809639
[TBL] [Abstract][Full Text] [Related]
13. LncRNA MALAT1 promoted high glucose-induced pyroptosis of renal tubular epithelial cell by sponging miR-30c targeting for NLRP3.
Liu C; Zhuo H; Ye MY; Huang GX; Fan M; Huang XZ
Kaohsiung J Med Sci; 2020 Sep; 36(9):682-691. PubMed ID: 32391974
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of the glycogen synthase kinase 3β-hypoxia-inducible factor 1α pathway alleviates NLRP3-mediated pyroptosis induced by high glucose in renal tubular epithelial cells.
Wan J; Jiang Z; Liu D; Pan S; Zhou S; Liu Z
Exp Physiol; 2022 Dec; 107(12):1493-1506. PubMed ID: 36056793
[TBL] [Abstract][Full Text] [Related]
15. Breviscapine alleviates podocyte injury by inhibiting NF-κB/NLRP3-mediated pyroptosis in diabetic nephropathy.
Sun L; Ding M; Chen F; Zhu D; Xie X
PeerJ; 2023; 11():e14826. PubMed ID: 36815984
[TBL] [Abstract][Full Text] [Related]
16. Hirudin ameliorates diabetic nephropathy by inhibiting Gsdmd-mediated pyroptosis.
Han J; Zuo Z; Shi X; Zhang Y; Peng Z; Xing Y; Pang X
Cell Biol Toxicol; 2023 Jun; 39(3):573-589. PubMed ID: 34212273
[TBL] [Abstract][Full Text] [Related]
17. Wogonin protects glomerular podocytes by targeting Bcl-2-mediated autophagy and apoptosis in diabetic kidney disease.
Liu XQ; Jiang L; Li YY; Huang YB; Hu XR; Zhu W; Wang X; Wu YG; Meng XM; Qi XM
Acta Pharmacol Sin; 2022 Jan; 43(1):96-110. PubMed ID: 34253875
[TBL] [Abstract][Full Text] [Related]
18. GSDMD-mediated pyroptosis: a critical mechanism of diabetic nephropathy.
Zuo Y; Chen L; Gu H; He X; Ye Z; Wang Z; Shao Q; Xue C
Expert Rev Mol Med; 2021 Dec; 23():e23. PubMed ID: 34955116
[TBL] [Abstract][Full Text] [Related]
19. Dapagliflozin prevents kidney podocytes pyroptosis via miR-155-5p/HO-1/NLRP3 axis modulation.
Zhang ZW; Tang MQ; Liu W; Song Y; Gao MJ; Ni P; Zhang DD; Mo QG; Zhao BQ
Int Immunopharmacol; 2024 Apr; 131():111785. PubMed ID: 38479158
[TBL] [Abstract][Full Text] [Related]
20. Triptolide inhibits oxidative stress and inflammation via the microRNA-155-5p/brain-derived neurotrophic factor to reduce podocyte injury in mice with diabetic nephropathy.
Gao J; Liang Z; Zhao F; Liu X; Ma N
Bioengineered; 2022 May; 13(5):12275-12288. PubMed ID: 35603354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
